In many countries, including the UK, the majority view among endocrinologists is that the failure of treatment to provide any demonstrable, measurable benefits in terms of outcomes means treatment is not recommended for all adults with severe GHD,[15] and national guidelines in the UK as set out by NICE suggest three criteria which all need to be met for treatment to be indicated: